Image Credit: Scientific Frontline / stock image
Scientific Frontline: Extended "At a Glance" Summary: Estrogen Link to Crohn's Disease
The Core Concept: A disruption in the NOD2 gene, which is critical for immune system activation, causes an unexpected increase in estrogen-related gene activity that drives the gut inflammation and dysfunction characteristic of Crohn's disease.
Key Distinction/Mechanism: While NOD2 mutations have long been associated with Crohn's disease, this research demonstrates that the loss of NOD2 function directly triggers estrogen-driven gut damage. Crucially, exposing healthy models to estrogen replicates this damage, and administering an estrogen receptor inhibitor to NOD2 mutants reverses the intestinal dysfunction.
Major Frameworks/Components:
- NOD2 Gene Mutation: The genetic anomaly responsible for failing to maintain standard gut health and immune response regulation.
- Estrogen Signaling Pathway: The hormonal mechanism that becomes hyperactive in the absence of standard NOD2 function, leading to widespread intestinal lining disruption.
- Zebrafish Modeling: The utilization of whole-organism living models to observe cell-specific gene activity and the interaction among genes, hormones, and immune responses.
- Sex-Biased Immunology: The study addresses a historical data gap where an overreliance on male animal models obscured the estrogen-dependent mechanisms that make females significantly more susceptible to Crohn's disease.
Branch of Science: Immunology, Endocrinology, Genetics, and Gastroenterology.
Future Application: The discovery provides a foundation for developing hormone-targeted therapies and personalized medical approaches for patients suffering from inflammatory bowel diseases.
Why It Matters: This research answers the longstanding question of why Crohn's disease disproportionately affects females and introduces a novel therapeutic target, estrogen receptor inhibition, to potentially reverse gut damage.
Scientists from the University of Bath (UK) have shed new light on how Crohn’s disease develops and why it affects people differently by finding new evidence of a link between a key immune system gene in the gut and signaling of the hormone estrogen.
Crohn’s disease affects around 250,000 people in the UK, causing chronic inflammation in the gut, with patients suffering from abdominal pain, diarrhea, and fatigue. The UK has one of the highest rates of inflammatory bowel disease in the world, with cases steadily rising.
In a new study published in the journal PLOS Biology, the researchers discovered that estrogen signaling plays a critical role in regulating gut health when the function of a gene called NOD2 is disrupted.
Their findings could open new opportunities to explore hormone-targeted therapies for inflammatory bowel diseases.
Mutations in the NOD2 gene—which activates the immune system and triggers an immune response—have long been associated with Crohn’s disease, but until now, it was unclear how this gene maintains gut health.
The researchers developed a zebrafish model of Crohn’s disease with a NOD2 mutation, observing which genes are active in every different type of cell found in the gut and comparing them with normal (wild-type) fish.
Estrogen Can Drive Gut Dysfunction
They found that the loss of NOD2 function causes widespread disruption in the gut, affecting both the intestinal lining and immune processes. Unexpectedly, they also found a marked increase in estrogen-related gene activity in the absence of NOD2.
When they exposed healthy fish to estrogen, they found that the hormone reproduced the same gut defects seen in the NOD2 mutants. Interestingly, they were able to reverse the gut damage in NOD2 mutants using an estrogen receptor inhibitor.
The researchers suggest that their results indicate the estrogen signaling pathway is worth investigating further.
Professor Edan Foley, from the Center for Evolution in the university’s Department of Life Sciences, said, “We’ve found a direct link between estrogen and the gut inflammation seen in Crohn’s disease.
“Our results show that regulating estrogen signaling is crucial for maintaining normal gut health and could explain why Crohn’s disease affects people differently.
“This discovery opens new ways of thinking about Crohn’s disease and could eventually lead to more personalized approaches to treatment.”
Data Gap Between Males and Females
Mckenna Eklund, a PhD student and the first author of the paper, said, “Inflammatory bowel disease affects so many people and is on the rise, but we don’t really know why.
“Crohn’s is more common in females than males, but historically, much of immunology research has relied heavily on male animal models, so there’s a huge data gap that we need to fill to find out what’s going on.
“Using zebrafish allows us to study gut biology in a whole living organism while generating large, well-controlled datasets, which is especially useful for investigating how genes, hormones, and immune responses interact.”
Published in journal: Plos Biology
Title: Estrogen impacts NOD2-dependent regulation of intestinal homeostasis
Authors: Mckenna Eklund, and Edan Foley
Source/Credit: University of Bath
Edited by: Scientific Frontline
Reference Number: imgy062426_01
.jpg)